Invesaro

Stocks Health care SHC

NASDAQ · Health care

Sotera Health Co (SHC)

Sotera Health Co brought in $1.2B of revenue over the twelve months to September 30, 2026, up 6.9% from a year earlier. Net income was $173.5M, a net margin of 14.1%. Operating cash flow minus capital spending left $149.2M of free cash flow in fiscal 2025. At September 30, 2026 it held $412.4M in cash against $2.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 3, 2026.

Free, no password. An email when SHC files with the SEC.

Price
$16.27
-1.03% on the day · November 10, 2026
52-week range $13.09 to $19.85
Market cap
$4.6B
Revenue (last 12 months)
$1.2B
+6.9% year on year
Net margin
14.1%
P/E
60.3
on FY2025 diluted EPS

Key facts about Sotera Health Co

Net worth
Sotera Health Co has a market value (market cap) of $4.6B at the latest share price, and shareholders' equity of $733.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $1.2B (+5.7% year on year), with net income of $77.9M. Over the 12 months to September 30, 2026: revenue $1.2B, net income $173.5M.
Cash flow
In fiscal 2025 operations brought in $287.2M of cash; after $138M of capital spending, free cash flow was $149.2M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 3, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Sotera Health Co's next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Sotera Health Co does

Sotera Health Co is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NASDAQ under the ticker SHC.

Revenue and profit by year

Revenue
FY19: $778.3M $778.3M FY19FY21: $818.2M $818.2M FY21FY21: $931.5M $931.5M FY21FY22: $1B $1B FY22FY23: $1B $1B FY23FY24: $1.1B $1.1B FY24FY25: $1.2B $1.2B FY25
Net income
FY19: -$20.9M -$20.9M FY19FY21: -$38.6M -$38.6M FY21FY21: $116.9M $116.9M FY21FY22: -$233.6M -$233.6M FY22FY23: $51.4M $51.4M FY23FY24: $44.4M $44.4M FY24FY25: $77.9M $77.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.2Bn/a$77.9M$0.27$149.2M
2024$1.1B$297.6M$44.4M$0.16$45.1M
2023$1B$276.7M$51.4M$0.18-$362.7M
2022$1B$248.4M-$233.6M-$0.83$95.6M
2021$931.5M$256.7M$116.9M$0.41$179.4M
2021$818.2M$206M-$38.6M-$0.16$67.1M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around January 11, 2027.

Estimated from its filing rhythm: 52 weeks after its report of January 12, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where SHC ranks in Health care

Revenue$1.2B
#146 of 751 in Health care · Top 19%
Revenue growth+5.7%
#342 of 532 in Health care · Bottom 36%
Net margin6.7%
#148 of 544 in Health care · Top 27%
Free cash flow margin12.8%
#101 of 490 in Health care · Top 20%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2021n/a$00%
2021n/a$0n/a
2019n/a$691.2Mn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Sotera Health Co has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 3, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 4.4% to $324.9M versus the same quarter last year; diluted EPS $0.20 versus $0.17.
  2. November 3, 2026
  3. October 30, 2026
  4. October 9, 2026
  5. August 14, 2026
  6. August 14, 2026
  7. August 14, 2026
  8. August 6, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.2% to $321.4M versus the same quarter last year; diluted EPS $0.19 versus $0.03.
  9. August 6, 2026
  10. July 30, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 19, 2026. Insider transactions on SEC

What is SHC worth? A DCF from its reported cash flow

Insider trades

What the people running Sotera Health Co did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $21.2M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$21.2M
last 90 days
Net sold
1,144,515
$21.2M
DateInsiderWhatSharesPriceValueFiling
August 17, 2026 Petras Michael B. Jr.Executive Chairman, Director Sold 294,515 $18.50 $5.4M Form 4
August 17, 2026 Petras Michael B. Jr.Executive Chairman, Director Soldindirect 850,000 $18.50 $15.7M Form 4
August 7, 2026 Rutz Michael PPresident of Sterigenics Sold 150,000 $18.84 $2.8M Form 4
August 5, 2026 Lyons Jonathan M.Sr. Vice President, CFO Shares withheld for tax 11,316 $17.98 $203.5K Form 4
May 26, 2026 Shader AltonChief Executive Officer, Director Received as pay 375,939 - - Form 4
May 26, 2026 Shader AltonChief Executive Officer, Director Received as pay 203,634 - - Form 4
May 22, 2026 Wheadon David E.Director Received as pay 14,970 - - Form 4
May 22, 2026 Simon, ChristopherDirector Received as pay 14,970 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SHC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Warburg Pincus Private Equity XI, L.P.13G, passive with 15 related filers 43.4% 123,038,253 November 14, 2024
Sessa Capital IM, L.P.13G, passive with 1 related filers 9.5% 27,050,000 August 14, 2026
Darsana Capital Partners LP13G, passive with 4 related filers 8.8% 25,000,000 November 14, 2025
Sculptor Capital LP13G, passive with 5 related filers 8.41% 24,000,000 August 14, 2026
Sessa Capital GP, LLC13G, passive with 5 related filers 7.23% 20,550,000 February 17, 2026
Vanguard Capital Management13G, passive 5.12% 14,625,165 October 30, 2026

Latest filings below 5%: Sachem Head Capital Management LP 0% (October 9, 2026); Warburg Pincus & Co. 0% (May 15, 2026); Gtcr Investment XI LLC 0% (May 15, 2026); The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 319 managers reported a position.

HolderSharesValueChange on quarter
Sessa Capital IM, L.P.27,050,000$480.1M+4,000,000
Darsana Capital Partners LP27,000,000$479.3M+1,000,000
BlackRock, Inc.24,148,424$428.6M+3,298,845
Sculptor Capital LP24,000,000$426M+2,282,272
Sachem Head Capital Management LP15,560,000$276.2M+3,915,000
Vanguard Capital Management LLC12,170,699$216M+1,435,693
Vanguard Portfolio Management LLC11,946,341$212M+1,337,624
Aqr Capital Management LLC10,734,313$186.4M+4,013,550
Jupiter Topco LLC8,402,106$149.1Mnew
State Street Corp8,324,321$147.8M+1,302,695
Fmr LLC6,173,320$109.6M+6,144,727
Two Seas Capital LP5,836,053$103.6M-187,318
Voss Capital, LP5,825,000$103.4M+953,730
Dimensional Fund Advisors LP5,799,870$102.9M+280,995
Geode Capital Management, LLC5,219,965$92.7M+580,066
Irenic Capital Management LP5,141,822$91.3M+782,474
DME Capital Management, LP4,135,515$73.4M+2,069,835
Lakewood Capital Management, LP3,979,581$70.6M-125,000
Norges Bank3,512,499$62.3Mnew
ION Fund Management Ltd3,343,648$59.3M+2,150,258

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

15 insiders reported holding 9,273,823 shares in total, about $150.9M at the last price.

HolderSharesAs of
Petras Michael B. Jr.Executive Chairman, Director 5,059,7323,969,393 held indirectly August 17, 2026
Rutz Michael PPresident of Sterigenics 1,265,033 August 7, 2026
Shader AltonChief Executive Officer, Director 955,512 May 26, 2026
Dimitrief AlexanderSVP, General Counsel and Sec. 632,021 March 31, 2026
Lyons Jonathan M.Sr. Vice President, CFO 629,480 August 5, 2026
Klee Ann R.Director 140,926 May 22, 2026
Petrella Vincent KDirector 95,751 May 22, 2026
Neary JamesDirector 95,751 May 22, 2026
Chen RuoxiDirector 95,751 May 22, 2026
Cunningham Sean LaurenceDirector 95,751 May 22, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SHC

What does Sotera Health Co do?

Sotera Health Co is a company in the Health care sector, listed on NASDAQ as SHC. Its shares trade on NASDAQ under the ticker SHC.

What is Sotera Health Co's net worth?

Sotera Health Co has a market value (market cap) of $4.6B at the latest share price, and shareholders' equity of $733.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Sotera Health Co profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $173.5M on revenue of $1.2B, a net margin of 14.1%.

How much revenue does Sotera Health Co make?

Over the twelve months to September 30, 2026 Sotera Health Co reported revenue of $1.2B. That is 6.9% more than a year earlier.

When did Sotera Health Co last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 3, 2026. It covers the period to September 30, 2026.

When is Sotera Health Co's next earnings report?

Sotera Health Co's next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare SHC with

Compare SHC with any company

Follow SHC

Get an email when Sotera Health Co files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SHC files with the SEC.

Where the numbers come from

Financial figures are the values Sotera Health Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.